Attention:

COVID-19 Top 10: What GCs need to Know about Coronavirus


Level: Advanced
Runtime: 60 minutes
Recorded Date: March 16, 2020
Click here to share this program
Download PDF

Agenda

  • Crisis Management
  • Employment
  • Privacy
  • Contracts
  • Tort Liability
  • Cybersecurity
  • Life Sciences
  • Fraud/Corruption Risk
  • Securities & Financial Regulation
  • Government Contracts
  • Global Perspectives
Runtime: 1 hour
Recorded: March 16, 2020

Description

This presentation will be supplemented by core crisis management principles and informed by David’s experience helping to lead the White House’s response to the Ebola crisis in 2014. David and Bethany will then dive into necessary strategies and considerations, ending with key takeaways and steps to employ moving forward.

This program was recorded on March 16th, 2020.

Provided By

American Bar Association

Panelists

David Newman

Partner
Morrison & Forester, LLP

David Newman is a partner in Morrison & Foerster’s Global Risk and Crisis Management, Privacy and Data Security, and National Security practice groups, and is head of the firm’s Coronavirus Task Force. David draws upon his experience as a senior White House and U.S. Department of Justice (DOJ) attorney, including serving as Chief of Staff, Office of the Ebola Response. He uses his extensive background in government regulation and national security to guide clients through sensitive matters pertaining to national security and crisis management. He has significant experience advising clients on crisis management and cybersecurity, counseling clients CFIUS and FARA reviews, and conducting internal and government-facing cross-border investigations.

Bethany J. Hills

Partner
Morrison & Forester, LLP

Bethany Hills is a partner in Morrison & Foerster’s FDA Regulatory + Life Sciences Compliance practice, and member of the firm’s Coronavirus Task Force. Bethany leverages her deep FDA regulatory experience and exceptional knowledge of the health care delivery system to help both domestic and international life sciences and health care technology clients enter and navigate the U.S. market. She helps companies manage the full range of FDA regulation issues, from inspections and investigations through complex regulatory challenges, affecting everything from product approvals and labeling to collaborative research, supply, and distribution agreements.


Similar Courses

Card image cap
77 minutes
§ 363 Sale Issues
Dive into Section 363 sales issues, including whether there are limits to “free and clear”; the GM conflict between Sections 365(h) and 363(f) (“lease-stripping”); sales free and clear of leasehold interests, restrictive covenants and override royalties; being free and clear of successorships in CBAs; selling free and clear of environmental liabilities (La Paloma, Exide); and loan-to-own strategies.

American Bankruptcy Institute

$75

Add to Cart
Card image cap
63 minutes
2018 CA Consumer Privacy Act: The Big Tail Wagging the U.S.
In this session, two leading information governance attorneys will share why you need to and how you can be ready.

Legalweek

$65

Add to Cart
Card image cap
60 minutes
2019 HIPAA Update: Enforcing Privacy & Security Standards
In this session, we will discuss the most critical issues in the HIPAA update and best practices for enforcing privacy & security standards in your company.

SuperConference

$65

Add to Cart
Card image cap
97 minutes
26 Words that Created the Internet - Basics of the Communications Decency Act Section 230 Safe Harbor
This program will examine the basics of CDA 230 and its day to day affect for those who advise internet businesses as well as those who litigate against them. It will give practical guidance as to what extend internet companies can or should edit or censor the information their users contribute to their sites and to what extent those users will actually be liable.

New Media Rights

$115

Add to Cart
Previous Next